U.S. Personal Products Stock News

NYSE:TFX
NYSE:TFXMedical Equipment

Does Teleflex's (TFX) Leadership Turmoil Recast the Story on Governance and Operational Resilience?

Teleflex announced it would host a conference call on February 26, 2026, to review its fourth-quarter 2025 results and provide an operational update, with live and replay audio available via the company’s website. This update comes soon after the abrupt departure of CEO Liam Kelly and the launch of a securities fraud investigation, raising fresh questions about governance and operational continuity. We’ll now examine how the CEO’s immediate departure and related securities fraud...
NYSE:NHI
NYSE:NHIHealth Care REITs

A Look At National Health Investors (NHI) Valuation After New Property Acquisitions And Analyst Rating Upgrade

National Health Investors (NHI) recently hit a 52 week high of $90.58 after announcing plans to acquire nine healthcare properties for $105.5 million, as well as additional investments across Kentucky, South Carolina, and Tennessee. See our latest analysis for National Health Investors. The recent property acquisitions come after a strong run, with the share price at $88.95 posting a 30 day share price return of 10.95% and a year to date share price return of 15.75%. The 1 year total...
NasdaqGS:PFG
NasdaqGS:PFGInsurance

How Principal’s Higher Dividend and US$1.5 Billion Buybacks Will Impact Principal Financial Group (PFG) Investors

Principal Financial Group, Inc. recently announced a first-quarter 2026 cash dividend of US$0.80 per share, a one-cent increase over the prior quarter and 7% higher than the same period a year earlier, alongside updates that it completed share repurchases totaling 16,965,356 shares for US$1.50 billion across previously announced buyback programs. The company also reported full-year 2025 revenue of US$15,625.5 million and net income of US$1,185.1 million, framing its higher dividend and...
NYSE:SUI
NYSE:SUIResidential REITs

Is Sun Communities (SUI) Offering Value After Mixed Multi Year Share Price Performance

Wondering if Sun Communities at around US$129.99 is offering fair value or a potential mispricing opportunity? This article walks you through what the numbers actually suggest. The stock has returned 1.7% over the last 7 days, 6.4% year to date and 10.9% over the last year, while the 30 day return sits at a slight 0.2% decline and the 3 and 5 year returns are 4.4% and 0.9% declines respectively. Recent coverage of Sun Communities has focused on its role as a large US real estate owner and...
NasdaqGS:PLTK
NasdaqGS:PLTKEntertainment

A Look At Playtika Holding (PLTK) Valuation After Credit Facility Refinance And Cost-Cutting Measures

What Playtika’s New Credit Facility Means for Investors Playtika Holding (PLTK) has amended and refinanced its existing revolving credit facility, keeping the size at $550 million while extending the maturity to March 2027 and maintaining similar terms. This debt move arrives alongside reaffirmed full year revenue and adjusted EBITDA guidance and ongoing cost cuts, including a planned 15% workforce reduction as the company increases its use of AI automation. See our latest analysis for...
NYSE:DBRG
NYSE:DBRGCapital Markets

Reassessing DigitalBridge Group (DBRG) After Its 44% One-Year Share Price Surge

If you are wondering whether DigitalBridge Group is still attractively priced after its recent run, looking closely at its valuation metrics can help you decide what the current share price really offers. The stock last closed at US$15.41, with returns of 0.0% over 7 days, 0.4% over 30 days, 0.2% year to date, 43.9% over 1 year, 13.5% over 3 years, and a 36.3% decline over 5 years. Taken together, these figures give a mixed picture of how the market has treated the shares over different...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Assessing Mirum Pharmaceuticals (MIRM) Valuation After Recent Share Price Momentum And Rare Disease Growth Prospects

Mirum Pharmaceuticals: Stock Moves and Business Snapshot Mirum Pharmaceuticals (MIRM) has seen its share price move recently, and investors are revisiting the biopharma name with its focus on rare and orphan liver diseases and a growing commercial portfolio. See our latest analysis for Mirum Pharmaceuticals. The recent 2.2% 1 day share price return, 15.4% 30 day share price return and very large 5 year total shareholder return suggest momentum has been building for Mirum, as investors react...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

BrightSpring Index Additions And Specialty Drug Deals Draw Valuation Focus

BrightSpring Health Services (NasdaqGS:BTSG) has been added to several S&P indices, including the S&P SmallCap 600 and S&P Composite 1500. The index changes highlight growing attention from institutional investors toward the company. Recent contract wins for high margin specialty drugs serving complex conditions are supporting business momentum. BrightSpring operates in healthcare services and specialty pharmaceuticals, areas that sit at the intersection of aging demographics, chronic...
NYSE:AIR
NYSE:AIRAerospace & Defense

Has AAR (AIR) Rallied Too Far After Aviation Supply Chain Optimism?

If you are wondering whether AAR's current share price lines up with its underlying worth, this article will walk through what the numbers are actually saying about value. AAR's stock last closed at US$114.63, with returns of 0.9% over the past 7 days, 9.1% over 30 days, 35.7% year to date, 78.3% over 1 year, 112.5% over 3 years, and 168.0% over 5 years, which may influence how much upside or downside you feel is left. Recent news coverage around AAR has largely focused on its role in the...
NasdaqCM:RCAT
NasdaqCM:RCATAerospace & Defense

A Look At Red Cat Holdings (RCAT) Valuation As New Drone Orders And ETF Interest Draw Attention

Red Cat Holdings (RCAT) is back in focus after new drone orders from Asia Pacific allies, deeper work in autonomous reconnaissance systems, a higher weighting in a defense ETF, and easing short interest reshaped recent sentiment around the stock. See our latest analysis for Red Cat Holdings. Those new orders and ETF inflows arrive as the share price sits at $12.08, with a 1 day share price return of 5.96% and a 90 day share price return of 96.74%. The 3 year total shareholder return is very...
NYSE:NATL
NYSE:NATLDiversified Financial

Is Expanded UnionPay Access at 13,000 Cashzone ATMs Altering The Investment Case For NCR Atleos (NATL)?

NCR Atleos recently expanded access for UnionPay cardholders, allowing them to withdraw cash at up to 13,000 Cashzone ATMs across the UK, many located in high-traffic and tourist areas. This collaboration underscores NCR Atleos’ role in cross-border cash access and tourism-related payments, reinforcing its position in self-directed banking infrastructure. We’ll now explore how this wider UnionPay access across Cashzone ATMs could influence NCR Atleos’ investment narrative and long-term cash...
NYSE:ALLY
NYSE:ALLYConsumer Finance

Ally Financial (ALLY) Valuation Check As Earnings Rebound And Share Buybacks Restart

Ally Financial (ALLY) is back in focus after its latest results showed year-over-year net income of US$300 million and a resumed US$2b share buyback, even as credit costs and margin pressures keep investors cautious. See our latest analysis for Ally Financial. The latest earnings and buyback news comes after a mixed stretch for the stock, with a 12.1% 90 day share price return but an 8.0% year to date share price decline. The 3 year total shareholder return of 55.5% suggests longer term...
NYSE:FE
NYSE:FEElectric Utilities

FirstEnergy (FE) Margin Improvement To 9.3% TTM Tests Bearish Profitability Narrative

FirstEnergy FY 2025 Earnings Snapshot FirstEnergy (FE) just posted its latest FY 2025 numbers with Q3 revenue of US$4.1 billion and basic EPS of US$0.76, setting a clear marker for how the year is shaping up. The company has seen revenue move from US$3.0 billion in Q4 2024 to US$3.4 billion in Q2 2025 and US$4.1 billion in Q3 2025, while quarterly EPS ranged from US$0.45 to US$0.76 over the same stretch, and trailing twelve month EPS sits at US$2.31 on revenue of US$14.3 billion. With net...
NYSE:MIR
NYSE:MIRElectronic

Did Record Orders and AI-Focused Leadership Just Shift Mirion Technologies' (MIR) Investment Narrative?

In February 2026, Mirion Technologies reported full-year 2025 revenue of US$925.4 million and net income of US$28.8 million, issued guidance for approximately low-twenties percentage revenue growth in 2026, announced record annual orders above US$1 billion, and reshaped its leadership team with new nuclear, nuclear medicine, and AI-focused roles. By elevating nuclear power and nuclear medicine leadership and appointing a Chief Artificial Intelligence & Digital Officer, Mirion is explicitly...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

A Look At Veracyte (VCYT) Valuation After UBS Reiterates Positive View On Q4 Revenue Performance

UBS reiterated its positive view on Veracyte (VCYT) after the company’s fourth quarter testing revenue topped expectations, highlighting higher average selling prices and prior period collections as key drivers, rather than underlying test volume trends. See our latest analysis for Veracyte. Veracyte’s share price has softened recently, with a 30-day share price return of an 11.93% decline and a year-to-date share price return of a 13.64% decline. This comes even though the three-year total...
NasdaqGS:TFSL
NasdaqGS:TFSLBanks

How Gator Capital’s Focus on TFSL’s Mutual Structure Has Changed TFS Financial’s Investment Story

In its fourth-quarter 2025 investor letter, Gator Capital Management disclosed that it had purchased a position in TFS Financial Corporation in December, citing the bank’s mutual holding company structure and the benefit of lower short-term interest rates. Gator Capital Management highlighted that this structure, combined with what it views as an underappreciated earnings recovery potential, could create an attractive, asymmetric risk/reward profile for public shareholders. With these...